REFERENCES
  1. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, 28 January 2020. World Health Organization 2020. https://apps.who.int/iris/handle/10665/330893.
  2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet.  2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5.
  3. Vijayan A, Humphreys BD. SARS- CoV-2 in the kidney: bystander or culprit?. Nat Rev Nephrol . 2020; 16: 703–704.https://doi.org/10.1038/s41581-020-00354-7.
  4. Sack MN. The enigma of anti-inflammatory therapy for the management of heart failure. Cardiovasc Res . 2020; 116:6-8. doi: 10.1093/cvr/cvz270.
  5. Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms.Life Sci . 2020;253:117723. doi:10.1016/j.lfs.2020.117723.
  6. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol . 2020;77(6):683-690. doi:10.1001/jamaneurol.2020.1127.
  7. Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow- up: JACC state of-the- art review. J Am Coll Cardiol . 2020; 75 (23): 2950–2973. doi: 10.1016/j.jacc.2020.04.031.
  8. Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol . 2020;138(5):575-578. doi:10.1001/ jamaophthalmol.2020.1291.
  9. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA . 2020. 323(13):1239-1242. doi: 10.1001/jama.2020.2648.
  10. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia.N Engl J Med . 2020;382(13):1199–1207. doi: 10.1056/NEJMoa2001316.
  11. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19.JAMA . 2020;324(6):603-605. doi: 10.1001/jama.2020.12603.
  12. Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March–June 2020. Morb Mortal Wkly Rep . 2020;69(30):993–8.
  13. Davido B, Seang S, Tubiana R, de Truchis P. Post–COVID-19 chronic symptoms: a postinfectious entity? Clin Microbiol Infect . 2020;26(11):1448–9. https://doi.org/10.1016/j.cmi.2020.07.028.
  14. Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol . 2021;93(2):1013-1022. doi: 10.1002/jmv.26368.
  15. Garg P, Arora U, Kumar A, Wig N. The ”post-COVID” syndrome: how deep is the damage? J Med Virol . 2021;93:673–674.https://doi.org/10.1002/jmv.26465.
  16. Centers for Disease Control and Prevention. Post-COVID conditions.https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html.
  17. Davis HE, Assaf GS, McCorkell L, et al. Characterizing Long COVID in an international cohort: 7 Months of symptoms and their impact. medRxiv . 2020.12.24.20248802. doi: https://doi.org/10.1101/2020.12.24.20248802.
  18. Tran VT,  Riveros C,  Clepier B,  et al. Development and validation of the long covid symptom and impact tools, a set of patient-reported instruments constructed from patients’ lived experience.medRxiv . 2021.03.18.21253903.  doi: https://doi.org/ 10.1101/2021.03.18.21253903.
  19. Garg M, Maralakunte M, Garg S, et al. The Conundrum of ‘Long-COVID-19ʹ: A Narrative Review. Int J Gen Med . 2021;14:2491-2506https://doi.org/10.2147/IJGM.S316708.
  20. Sudre, CH, Murray B, Varsavsky T, et al.  Attributes and predictors of long COVID. Nat Med.  2021; 27:  626–631.https://doi.org/10.1038/s41591-021-01292.
  21. Repišti S, Jovanović N, Kuzman MR, et al. How to measure the impact of the COVID-19 pandemic on quality of life: COV19-QoL – the development, reliability and validity of a new scale” Global Psychiatry. 2020; 3(2):201-210.https://doi.org/10.2478/gp-2020-0016.
  22. Sümen A, Adibelli D. Adaptation of the COV19-QoL Scale to Turkish culture: Its psychometric properties in diagnosed and undiagnosed individuals. Death Stud . 2021 doi: 10.1080/07481187.2021.1925376. Epub ahead of print.
  23. Diamond JJ, Becker JA, Arenson CA, Chambers CV, Rosenthal MP. Development of a scale to measure adults’ perceptions of health: priliminary findings. J Community Psychol. 2007;35(5):557-61.  https://doi.org/10.1002/jcop.20164.
  24. Kadıoğlu H, Yıldız A. Validity and reliability of Turkish version of perception of health scale. Turkiye Klinikleri J Med Sci. 2012; 32(1): 47-53. doi:10.5336/medsci.2010-21761.
  25. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/.
  26. Del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA. 2020;324(17):1723-1724. doi: 10.1001/jama.2020.19719.
  27. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27: 601–615.https://doi.org/10.1038/s41591-021-01283-z.
  28. Boscolo-Rizzo P, Guida F, Polesel J, et al. Long COVID in adults at 12 months after mild-to-moderate SARS-CoV-2 infection. medRxiv . 2021.04.12.21255343. doi:https://doi.org/10.1101/2021.04.12.21255343.
  29. Shah R, Ali FM, Nixon SJ, et al. Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey. BMJ Open . 2021;11:e047680. doi: 10.1136/bmjopen-2020-047680.
  30. Rosa RG, Robinson CC, Veiga VC, et al. Quality of life and long-term outcomes after hospitalization for COVID-19: Protocol for a prospective cohort study (Coalition VII). Rev Bras Ter Intensiva . 2021;33(1):31-37. doi: 10.5935/0103-507X.20210003.
  31. Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect . 2020;81(6):e4-e6. doi:10.1016/j.jinf.2020.08.029.
  32. Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open . 2021;4(2):e210830. doi:10.1001/jamanetworkopen.2021.0830.
  33. NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE Guideline Published: 18 December 2020. www.nice.org.uk/guidance/ng188.